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collimator: a dosimetric comparison for large or
critically located arteriovenous malformations
Sławomir Blamek1*, Aleksandra Grządziel2 and Leszek Miszczyk1Abstract
Background: Stereotactic irradiation of large or critically located arteriovenous malformations (AVMs) is a special
challenge for clinicians and radiation physicists. To date, no comprehensive comparison of two linac-based
radiosurgery systems used for hypofractionated radiotherapy of large AVMs was published. The aim of the study
was to compare dose distributions between CyberKnife (CK) system and linac with a micro-multileaf collimator
(L-mMLC) in high-grade or critically located cerebral AVMs.
Methods: Two sets of plans made for 15 different patients with at least 95% target coverage were selected for
comparisons. Conformity (CI), homogeneity (HI) and gradient score (GSI) indices, conformity index proposed by
Lomax (CIL), conformation number (CN), quality of coverage (Q), volumes of brain receiving 12,10,8,6,4, and 2 Gy,
minimum and maximum doses for critical structures in both treatment planning systems (TPS) were compared.
Finally, the number of monitor units needed to deliver the prescribed dose was compared.
Results: The mean minimum doses in the target volume were 93.3% (CK) and 90.7% (L-mMLC),p=n.s, maximum:
119.7 and 110%, respectively (p=0.004). The mean CI was 1.46 and 1.86, HI: 1.2, and 1.11, CIL 0.7, and 0.6, CN: 0.68
and 0.58 for CK and mMLC, respectively (p<0.05). The values of GSI and Q were not significantly different. The
volumes of the brain receiving low doses (4 Gy and 2 Gy) were significantly lower in the CK system. The number of
monitor units necessary to deliver the prescribed dose was significantly greater in case of the CK system.
Conclusions: Better conformity can favor the CK system for treatment of large AVMs at the cost of higher
maximum doses and worse homogeneity. L-mMLC is superior when shorter treatment time is required. Neither
system can assure satisfying dose gradients outside large targets surrounded by numerous critical structures.
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Large and critically located arteriovenous malformations
are consistently a challenge for clinicians. Traditionally a
“wait and see” policy was proposed to patients harboring
AVMs unsuitable for surgery, efficient endovascular
treatment or stereotactic radiosurgery. Recent literature
indicates however, that large size of an AVM can be an
independent risk factor of bleeding which stands in con-
trast to conclusions drawn from the earlier studies [1].
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reproduction in any medium, provided the orFinnish group provided evidence that active, even partial
treatment may be of benefit for patients with cerebral
AVMs [2]. Better understanding of the natural and al-
tered by the treatment course of the disease results with
growing interest in treatment of large-volume lesions.
Advances in microneurosurgery allow for removal of
previously inaccessible lesions and patients unfit for
surgery are more often qualified for stereotactic radio-
therapy. AVMs involving critical structures can be
treated with hypofractionated stereotactic radiotherapy
(HFSRT), whereas lesions of large volume are suitable
both to volume-staged radiosurgery and HFSRT [3,4].
Gamma knife, linear accelerators and heavy ion ir-
radiation have a long history of use for treatment ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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first device used for stereotactic radiosurgery for cerebral
AVMs [5-8]. Along with development of linear accelera-
tors both specialized accessories like micro-multileaf colli-
mators and dedicated units for radiosurgery become
available and widely used. The micro-multileaf collimator
(mMLC) allows for field shaping and intensity modulation
which is not possible in case of gamma knife system. As a
next step of development of linear accelerators, the
CyberKnife (CK) system was built. Its capabilities resem-
ble those characteristic for gamma knife. Additionally, it
does not require invasive fixation of the head because
of continuous tracking and correction for intrafraction
movements. Although the most recent model of the
gamma knife device – GammaKnife Perfexion can also be
used for fractionated treatment with immobilization with
a mask, still a vast number of gamma knife centers utilize
the older models. The CyberKnife system is currently used
for treatment of various conditions like primary or meta-
static malignant neoplasms and non-neoplastic lesions
including arteriovenous malformations. The published
results of treatment are uncommon but resemble that
obtained with other radiosurgery systems [9,10]. The
literature dealing with dose distribution generated by the
CyberKnife system in radiosurgery for AVMs in relation
to other radiosurgery is even more scarce [3,11]. To date,
no comparisons between CK and linear accelerator with
micro-multileaf collimator (L-mMLC) were made for
large-volume lesions treated with hypofractionated stereo-
tactic radiotherapy.
The aim of the current study was to compare dose
distributions obtained in the CyberKnife system and
in the system composed of a linear accelerator with a
mMLC for large, involving, surrounding or abutting
critical structures arteriovenous malformations.
Methods
Patients
15 patients with high-grade or critically located AVMs
were selected and included into the study. The mean
volume of the lesion was 21.7 cm3 and ranged from 1.02
to 146.45 cm3. There were 11 Spetzler-Martin grade III,
3 grade IV, and 1 grade V AVMs. All lesions were lo-
cated in close proximity or involved critical structures
like brainstem or optic pathway. Due to complicated
shape of the AVMs there was no reliable metrics to be
used to describe the lesions. As there is no proper data
in treatment planning systems (for instance the surface
of the target) to calculate the sphericity value, it could
not be used to describe the shape of the PTVs. Potential
approach to roughly estimate the surface of the PTV
would in our opinion lead to obtaining values with error
significantly larger than the accuracy the other values
were measured and thus, it would lead to unreliableresults of comparisons. The measure of sphericity deter-
mined by measuring three linear dimensions is in our
opinion an insufficient method to describe shapes of
complicated 3D objects. The diameters vary significantly
with the subsequent CT scans (Figure 1). Therefore, def-
inition of the matrix of the diameters would be required.
For the same reasons we rejected the idea to define the
sphericity on the basis of the radius measured from the
center of gravity of the target. To give an idea of the
complexity and location of the target volumes and of steep-
ness of dose fall-off necessary to preserve the critical struc-
tures we have chosen to present the three-dimensional
reconstructions of the target volumes to depict their com-
plexity and relation to organs at risk (Figure 2). Moreover,
detailed description of the AVMs with their volumes and
relation to OARs is presented in the Table 1.
Radiosurgery-based AVM score was also calculated for
each lesion and had a mean value of 3.13 (range: 1.07 to
15.41). Radiosurgery-based AVM score is calculated
according to the following formula: AVM score = 0.1
volume (mL) + 0.02 age (years) + 0.3*location, where
location is a two-tiered variable depending on the lo-
cation of the AVM: for hemispheric, corpus callosum
and cerebellar location it has the value of 0, whereas
for AVMs located in basal ganglia, thalamus and brain-
stem it is equal to 1 [12]. AVM score allows for prediction
of treatment outcome and the greater the value the
smaller probability of obliteration after stereotactic ir-
radiation [12].
Imaging, target definition and dose prescription
All the imaging data were imported into the MultiPlan
treatment planning system (TPS) developed for the
CyberKnife system. Radiosurgery planning was based on
computed tomography (CT), post-contrast T1 and FLAIR
magnetic resonance images (MRI), and magnetic reson-
ance angiography (MRA). Image fusion was performed
using an automated intensity-based algorithm that maxi-
mizes the mutual information of the loaded images, and
corrected manually when necessary. The target volume
and critical organs (brainstem, optic nerves, optic chiasm,
optic tracts, pituitary gland, eyeballs, lenses, and unin-
volved brain) were delineated in the MultiPlan system and
subsequently transferred to iPlan TPS without modifica-
tions. The target volume was defined as the AVM nidus
without draining veins, whereas organs at risk (OARs)
were outlined according to anatomy. Prescription of the
dose was based on size and location of the AVM and
proximity of organs at risk. In all cases hypofractionation
was chosen to assure tolerable doses for organs at risk and
to avoid irradiation of large volumes of the brain with high
doses. According to our protocols, three fractionation
schedules were used: 3 × 7 Gy, 3 × 8 Gy, and 4 × 6 Gy. All
the reported total doses for the target volume are an
Figure 1 An example of a complex shape of an AVM. A – 3D representation of the target volume. AVM has a complicated shape and is
located next to the brainstem and encompasses the left optic nerve. B – transverse view of the lower part of the AVM, projection of the
isocenter is near the edge of the target volume, radii measured from this point would be significantly different from those measured at the level
of the isocenter. C – sagittal view of the AVM at the level of the isocenter. The shape at this level appears to be quite regular. The target volume
is adjacent to the brainstem. D – coronal view of the AVM, irregular shape of the AVM is visible better than on the sagittal projection.
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maximum and mean doses are maximum and mean
values of the total dose. Similarly, the doses delivered to
organs at risk are physical doses calculated for the whole
treatment plan (all fractions). No calculation of biological
equivalent doses was performed.
Treatment planning - CyberKnife
All treatment plans were prepared in the MultiPlan ver-
sion 4.5.0 (Accuray Incorporated, Chesapeake Terrace
Sunnyvale, CA, USA). In all cases fixed cylindrical colli-
mators were used. We did not use the Iris collimator
in order to assure maximum steepness of dose falloff
resulting from narrower penumbra of fixed collima-
tors, and to avoid dose uncertainties that can be expected
when the smallest diameters of the Iris collimator are used
[13]. All plans were made with nonisocentric inverse-
planning technique. In all cases shells were used to assure
steep dose gradient outside the target volume. The num-
ber and diameter of collimators were selected individually,
according to the size and shape of the lesion. The pencil-
beam algorithm was used for dose distribution calculation.
The number of beams used ranged from 76 to 375 (mean
and median 183, and 171, respectively). The optimizationprocess was repeated until no further improvement re-
garding dose distribution and critical organs constraints
could be achieved.
Treatment planning - linear accelerator with mMLC
Treatment plans for L-mMLC were made with iPlan ver-
sion 4.1.1 (Brainlab AG, Feldkirchen, Germany) for the
m3 micro-MLC (Brainlab AG, Feldkirchen, Germany)
with leaf width of 3 mm at the isocenter. In all cases
both intensity-modulated radiosurgery plans (IMRS) and
plans with a set of fixed-angle static fields were pre-
pared. The number of beams ranged from 9 to 15 (mean
and median 12). The gantry angles and leaf positions
were manually adjusted in the static-field plans to
achieve the best dose distribution. IMRS plans were op-
timized as long as no further improvement in dose dis-
tribution could be gained. Plans with dynamic conformal
arcs were also prepared. They were however not useful
and were not selected for comparisons because of un-
acceptable dose distribution in case of large and irregu-
larly shaped target volumes. According to our experience
dynamic conformal arcs give the best results for small tar-
get of spherical or ellipsoid shape. Similar findings (better
performance of dynamic conformal arcs for smaller
Figure 2 Three-dimensional views of the target volumes.
A – case 1 – large AVM close to the optic chiasm and brainstem.
B – case 2 - large AVM involving brainstem and close to the optic
pathway. C – case 3 - large AVM encompassing the right optic
nerve and close to the brainstem, optic chiasm and right optic tract.
D – case 4 - small AVM located inside the brainstem. E – case
5 – small AVM next to the brainstem, F – case 6 – irregular AVM
partially located inside the brainstem, G – case 7 – irregular AVM
next to the brainstem, H – case 8 – AVM next to the brainstem,
I – case 9 – AVM adjacent to the right optic nerve, J – case 10 - AVM
involving the brainstem, K – case 11 – large AVM encompassing the
left optic nerve and adjacent to the optic chiasm and brainstem,
L – case 12 – AVM adjacent to the right optic tract and close to the
optic chiasm, M – case 13 – AVM involving the brainstem and
adjacent to the optic chiasm, N – case 14 - AVM inside the brainstem
and adjacent to the left optic tract, O – case 15 – large AVM adjacent
to the brainstem and optic chiasm.
Table 1 Detailed characteristics of arteriovenous
malformations included into the study with respect to







1 29.30 9.4 chiasm neighboring
2 24.67 0 brainstem involving
3 22.93 0 optic nerve R encompassing
4 1.02 0 brainstem within
5 1.14 1 brainstem neighboring
6 4.72 0 brainstem involving
7 3.17 1.3 brainstem neighboring
8 5.62 1 brainstem neighboring
9 11.78 2.2 optic nerve R neighboring
10 13.66 0 brainstem involving
11 146.45 0 optic nerve L encompassing
12 17.76 0 optic tract R adjacent




14 6.42 0 brainstem within
15 27.83 0 brainstem adjacent
L -left, R – right, neighboring – the PTV is located at some distance from the
nearest OAR, involving – the PTV is partially inside the nearest OAR,
encompassing – the PTV surrounds the nearest OAR, adjacent – the PTV is in
contact with the nearest OAR but does not surround or involve it, within – the
whole PTV is inside an OAR.
Table 2 Dose constraints used for the hypofractionated
schedules of stereotactic irradiation





Optic chiasm 6.5 6
Optic nerves 6.5 6
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iority of IMRT over dynamic conformal arcs for stereotac-
tic irradiation of complex, concave or irregular target
volumes was also demonstrated by Sharma et al. [15]. The
plans were compared within the TPS and the optimal
plans that in the greatest degree fulfilled the predefined
criteria were chosen for further comparisons.Plan selection criteria and comparisons
All plans were prepared by the same experienced radio-
surgery team in working in our Center and utilizing both
treatment systems (around 5000 patients treated with a
linear accelerator with mMLC and about 900 with CK
until now). All plans were optimized to assure at least
95% coverage of the target volume with the prescribed
dose to facilitate further comparisons. Moreover, the
plans had to fulfill the predefined dose constraints for
organs at risk as it is defined in the protocols used in
our Department (Table 2). The best plans with the
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were selected for comparisons.
The plans were evaluated by analysis and comparison
of dose-volume histograms (DVH) for AVMs and organs
at risk, target coverage, and two indices proposed by the
Radiation Therapy Oncology Group (RTOG) do describe
the quality of stereotactic radiosurgery plans: conformity
index (CI), and homogeneity index (HI) [16]. CI is
defined as a ratio of total volume covered by refer-
ence isodose and the target volume, whereas HI is
defined as a ratio of maximum dose in the target vol-
ume and the prescribed dose. Moreover, quality of
coverage (Q), conformity index proposed for evalu-
ation of radiosurgery treatment plans by Lomax and
Scheid (CIL), conformation number (CN) and gradient
score index (GSI) were calculated for each plan.
Quality of coverage is a ratio of the minimum dose de-
livered to the target volume and the prescription isodose
[16]. CI, HI, and Q indices were analyzed according to
the criteria proposed by RTOG to evaluate the quality of
radiosurgery [16]. CIL is defined as a ratio of the volume
within the target irradiated with at least the prescription
dose and the total volume enclosed by the prescription
isodose [17]. Conformation number was originally intro-
duced to quantitatively assess the degree of conformality
in brachytherapy and can be treated as a measure of the
quality of the plan [18]. It is defined as follows:
CN ¼ TVRI=TV  TVRI=VRI;
where TVRI is the target volume covered by the ref-
erence isodose, TV is the target volume, and VRI is
the volume of the reference isodose. Gradient score
index (GSI) is a measure of the steepness of the
dose falloff outside the target volume [19]. It is cal-
culated as follows:
GSI ¼ 100−100  REff50%IDV−REffPTVð Þ−0:3½ 
where REff50%IDV is the effective radius of the 50% iso-
dose volume, whereas REffPTV is the effective radius
of the target volume assuming that both volumes are
spheres [19].
To facilitate comparisons, improvement ratios for each
evaluated parameter were calculated and expressed as a
percentage of improvement or deterioration (Δ HI, Δ CI,
Δ CIL, Δ Q, Δ CN, and Δ GSI). Improvement ratios were
defined as follows:
Δ EP ¼ EPCK‐EPL‐mMLCð Þ=EPL‐mMLC  100%
where Δ EP is the improvement ratio of the evaluated
parameter, EPCK is the evaluated parameter calculated
for CK, and EPL-mMLC is the evaluated parameter calcu-
lated for L-mMLC.Another step of plan evaluation was calculation and
comparison of low, medium, and high isodose volumes
(IDV) of 2, 4, 8, 10, and 12 Gy (IDV2Gy, IDV4Gy, IDV8Gy,
IDV10Gy, and IDV12Gy, respectively) for each plan. The
isodose volumes were represented both by absolute
values (in cm3) and percentage of total tissue volume
(IDV2Gy%, IDV4Gy%, IDV8Gy%, IDV10Gy%, and IDV12Gy%,
respectively).
Moreover, three volume ratios were calculated to add-
itionally assess the steepness of the dose falloff outside
the target volume. The first one was the ratio of 80%
IDV to PTV, then 60% IDV/PTV and 40% IDV/PTV.
Comparison of the volumes receiving 80%, 60% and 40%
of the dose to the volume of the target allows for quanti-
tative assessment of the dose gradient. The smaller the
ratios the steeper is the dose gradient [20].
As the final step, the number of monitor units necessary
to deliver the demanded dose was compared. It can be
considered a surrogate of the time needed to complete the
treatment. Whereas the MultiPlan TPS calculates the esti-
mated treatment time per fraction (ETTPF), similar infor-
mation is not available in the iPlan TPS which was the
reason to use the number of monitor units for com-
parisons. The research was in compliance with recom-
mendations of the Helsinki Declaration (1964, with
later amendments). Approval of the institutional Ethics
Committee is not required in our Institution for a dosi-
metric study performed on existing imaging data.
All statistical comparisons were made with Student’s
t-test for dependent samples. The differences were con-
sidered statistically significant if p values were < 0.05. All




In all cases the 95% coverage of the target volume could
be obtained. The mean coverage for the CK and L-mMLC
was 97.9% and 96.7%, respectively, and the difference was
not significant. In three plans made for L-mMLC and in
one for the CK system (point maximum dose for brain-
stem of 28.57 Gy in the four-fractions regimen), the dose
constraints for critical structures were violated. The mini-
mum doses for the target volumes were comparable
(mean 93.3% and 90.7%, for the CK and L-mMLC, re-
spectively), whereas the maximum doses were significantly
larger in the CK system (mean 119.7%) than in case of
L-mMLC (mean 110%), p<0.05. The mean CI was
1.48 and 1.86 for CK and L-mMLC, respectively
(p<0.05). In none of the CK plans the CI was greater than
2 and thus all plans were compliant with the RTOG proto-
col. In contrast, three L-mMLC plans had minor deviation
and one with the CI value of 2.83 had a major deviation.
The difference in conformity was further confirmed by
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the HI revealed that all the plans could be classified as not
deviating from the RTOG protocol. Nevertheless, the dif-
ference between homogeneity indices between systems
was highly significant (p<0.05). The Q value was found to
be below 90% in two CK plans (83% and 67%, minor and
major deviation, respectively), and in four L-mMLC plans
(85%, 80%, 79% and 73% - two minor and two major devia-
tions). The subsequent IDVs were larger in the L-mMLC
system. The differences between high-dose isodose vol-
umes were not statistically significant. The low dose IDVs,
however, (IDV4Gy% and IDV2Gy%) were significantly larger
in plans made for L-mMLC (Table 3) indicating that low-
dose isodoses were better conformed to the target volume
in the CK system.
The improvement ratios for HI (ΔHI) ranged between
−4.2 and 19.8% with the majority (12) positive values indi-
cating better homogeneity in most L-mMLC plans. ΔCI
ranged from −44 to 23.3% with the majority (13) of nega-
tive values indicating better conformity in the majority of
CK plans. Mean values of the other measures and their
improvement ratios are summarized in Table 4.
The 80% IDV/PTV, 60% IDV/PTV and 40% IDV/PTV
ratios were comparable between systems indicating that
the dose gradient did not differ significantly between CK
and L-mMLC.
Critical organs sparing
The dose distribution within critical organs was different
between systems. There were significant differences in the
maximum dose in the brain with and without the target
volume. Higher point maximum doses were observed inTable 3 Comparison of subsequent isodose volumes
between CK and L-mMLC systems
CK ±SD L-mMLC±SD P value
IDV12Gy 61.77±66.58 70.04±75.15 0.09
IDV12Gy% 4.40±4.62 6.08±5.72 0.10
IDV10Gy 83.43±83.70 96.50±98.75 0.07
IDV10Gy% 5.96±5.8 8.26±7.35 0.08
IDV8Gy 118.03±105.52 137.12±135.49 0.09
IDV8Gy% 8.48±7.31 11.72±10.10 0.07
IDV6Gy 179.76±138.73 218.55±188.09 0.04
IDV6Gy% 12.90±9.66 18.44±13.79 0.03
IDV4Gy 308.33±192.27 385.71±263.30 0.01
IDV4Gy% 22.17±13.46 31.92±18.48 <0.05
IDV2Gy 583.20±264.75 608.47±316.86 0.58
IDV2Gy% 41.90±18.35 50.40±22.08 0.04
CK-CyberKnife, L-mMLC – linac with micro-multileaf collimator,
SD – standard deviation.
Volumes are presented both in absolute values and as ratios to total
tissue volume.
Significant differences are marked with bold font.case of the CK system. The detailed analysis shows also
that the mean maximum doses for organs at risk are
slightly higher in case of robotic radiosurgery but the dif-
ference was significant only for one structure – the left
optic nerve. The detailed comparison is shown in Table 5.
Treatment time and number of monitor units
The difference between the number of monitor units
needed to deliver the planned dose was highly significant
(p<0.05). In all cases then number of monitor units was
greater for the CK system (Table 6).
Discussion
According to the best knowledge of the authors this
is the first paper to describe the comparison of dose
distribution between CK and L-mMLC for large, crit-
ically located and mostly irregularly-shaped targets
characteristic for high-grade AVMs. The comparisons
published to date were mainly focused on small or
medium-sized and roughly spherical targets, like in
case of cerebral metastases, acoustic neuroma or tri-
geminal neuralgia [21,22]. In the paper dealing with
dosimetric comparisons of stereotactic radiosurgery
realized with the GammaKnife Perfexion, CyberKnife
and Novalis-Tx for cerebral AVMs, the target volumes
are relatively small with the mean and median volume
of 6.12 and 3.76 cm3, and ranging between 0.51 and
17.16 cm3 [11]. This makes such comparisons similar
to the other studies [21,22]. Foght et al. published a
study on seven patients with AVMs of the mean vol-
ume of 11.3 cm3 and ranging between 8 and 15 cm3
[3]. They compared only conformity and homogeneity
indices and 12 Gy isodose volume between the
GammaKnife Perfexion and the CyberKnife. The
current study is based on an analysis of dose distribu-
tion for critically located targets of wide range of vol-
umes with the mean volume almost twice as high as
published to date and exceeding the maximum vol-
umes of AVMs described in the comparison studies
until now [3,11]. All the AVMs were located in close
vicinity or involved critical structures. As selecting targets
of similar (small or large) volumes could unintentionally
lead to a bias favoring one system (CK was reported to
better spare critical organs in case of small targets like ves-
tibular schwannoma), a diverse set of AVMs of different
volumes was chosen to assure reliable comparisons be-
tween the systems [21]. The literature dealing with dosi-
metric comparisons of the CyberKnife system with other
treatment modalities is sparse and thus, confrontation of
our results with outcomes reported by other authors is
difficult because of other types of lesions described or dif-
ferent population of patients with AVMs included in the
other studies [3,11,21,22]. As a consequence, the results of
the current study give an additional information on the
Table 4 Mean values of the evaluated indices for all plans in both systems
System HI ΔHI (%) CI ΔCI (%) CIL ΔCIL (%) GSI ΔGSI (%) CN ΔCN (%) Q ΔQ (%)
CK 1.20 8.1 1.48 −20.43 0.70 16.60 26.38 −25.30 0.68 17.24 0.93 3.33
L-mMLC 1.11 1.86 0.60 35.32 0.58 0.90
P value <0.05 <0.05 <0.05 0.26 <0.05 0.28
CK-CyberKnife, L-mMLC – linac with micro-multileaf collimator, HI – homogeneity index, CI – conformity index, CIL – conformity index proposed by Lomax,
GSI – gradient score index, CN – conformation number, Q – quality of coverage, Δ – improvement ratio of a given measure (%).
Significant differences are marked with bold font.
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plans on volume of the lesion and its relation to critical
structures which cannot be found elsewhere.
The coverage of the target was comparable in both
systems being slightly higher in the CK system. The
mean Q was high in both systems indicating that in
most cases the nidus was covered with the desired dose
without significant cold spots. Detailed analysis shows
however, that the number of deviations from the RTOG
protocol was twice as high in case of the L-mMLC than
as for the CK system. Observed deviations resulted from
the need for sparing adjacent OARs. This treatment
planning objective could be obtained with better quality
of coverage with the CK system in the current series.
Analysis of conformity indices demonstrated that bet-
ter conformity can be obtained with the CK system.
However, in both systems minor deviations from RTOG
protocol were noted. In case of the L-mMLC also one
major deviation was observed. Apart from the one major
deviation, the rest of the plans could be considered satis-
factory basing solely on the CI. The CIL also indicates
that conformity of the plans is significantly better in case
of the CK system (higher CIL values mean better con-
formity as opposed to CI) and are within the range






Brain 27.91 25.67 <0.05
Uninvolved brain 27.64 25.56 <0.05
Brainstem 20.69 20.42 0.72
Optic chiasm 12.33 11.80 0.39
Left optic nerve 7.57 5.58 <0.05
Right optic nerve 8.13 6.90 0.09
Left optic tract 12.21 12.01 0.83
Right optic tract 13.56 12.98 0.45
Left eyeball 3.97 2.97 0.05
Right eyeball 3.58 2.58 0.08
Left lens 0.46 0.59 0.47
Right lens 0.54 0.46 0.61
Pituitary 10.73 9.85 0.16
Significant differences are marked with bold font.both conformity indices are on the order of 20 and 16%,
which further confirms the superiority of the CK system.
Neither the optimization algorithm during the inverse
planning of IMRS nor experience and expertise in beam
arrangement and shaping in case of static fields could
assure conformity equal to that obtained with the
CyberKnife system. The better the conformity, the less
uninvolved tissue is exposed to high doses of radiation
which has a direct impact on the risk of radiation-
induced side effects. The incidence of radiation-induced
abnormalities seen in MR imaging is reported to be
around 30% and the risk of occurrence of the alterations
and symptomatic injury increases with increased vol-
umes irradiated to higher doses, e.g. 12 Gy [23,24]. More
detailed analysis of dose distribution, however, shows
that the degree of conformity and dose gradient around
target volumes are less satisfactory than expected. The
mean conformation numbers between 0.6 and 0.7 indi-
cate that the ability of sculpting the isodose distribution
around the nidus is limited in both systems. This is the
result of specific arrangement of the beams being the
consequence of avoiding OARs and delivering the dose
to large target volume at the same time. Spreading the
dose among the critical structures caused lower degree
of conformation and influenced also the dose gradient
away from critical structures.
GSI values were below expectation in both systems.
This is the result of irradiation of large target volumes
surrounded by numerous critical structures. The need
for sparing organs at risk requires nonuniform beam ar-
rangement with most of the beams placed in a way
allowing to avoid direct irradiation of critical structures.
It allows for steep dose gradients in regions adjacent to
OARs but at the cost of dose spillage between them.
The resulting dose falloff in regions where beams are ac-
cumulated is far from the steep gradient next to the crit-
ical structures. The effect of accumulation of the beams
is aggravated in most cases by their large diameter which
results with partial overlapping of the neighboring
beams. The improvement ratio calculated for GSI was
relatively high, the difference between system was how-
ever not significant. This is the result of large range of
obtained values in both systems being the consequence
of diverse volumes of the AVMs. Choosing more homo-
geneous group of targets in terms of their volume could
Table 6 Number of monitor units (MU) per fraction specified for consecutive cases for the CyberKnife system (CK) and
linac with micro-multileaf collimator (L-mMLC)
Case number
System 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
CK 8210 25495 9616 6852 10984 14199 16649 10838 6611 12165 10188 9969 9773 7699 9063
L-mMLC 1021 815 917 903 1057 842 1145 1140 1057 823 843 949 833 858 768
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cost of possible unwanted favoring of one system. The
similarity of dose gradient was further confirmed by
the analysis of ratios of subsequent isodose volumes to
the target volume revealing lack of significant differences
in all cases. It means that in both systems irradiation of
volumes requiring steep dose gradients next to the crit-
ical structures is associated with wide dose gradient in
regions to which dose restrictions are not applied.
The maximum doses delivered to critical organs were
slightly higher mainly in the CyberKnife system. This
can be the result of better dose coverage and quality of
coverage obtained in the CyberKnife system and thus,
slightly higher doses on the surface of the lesion abutting
critical structures. Moreover, the differences were not
statistically significant (apart form the left optic nerve
which not necessarily is the result of superiority of one
system but may be due to a chance). The observed out-
comes may result from heterogeneity of the group (both
large AVMs and relatively small lesions but located in
the vicinity of critical structures were included) and lim-
ited number of the cases analyzed. As a consequence,
the study can be underpowered to demonstrate signifi-
cant differences between systems. On the other hand,
the number of cases included into the current study is
the largest in the literature dealing with dosimetric com-
parisons of stereotactic radiosurgery systems in the set-
ting of AVM treatment [3,11]. Higher maximum doses
and worse homogeneity in case of CK can potentially
affect the treatment outcome. Whether the differences
in quality measures observed in the current study are of
clinical importance is an open question and require a
clinical study. In clinical practice the plans selected for
treatment would probably be those with safe doses to crit-
ical organs at the cost of slightly lower coverage of the tar-
get volume. However, for the purpose of the study we have
chosen to define uniform selection criteria (i.e. 95% cover-
age and dose constraints for critical organs), to reliable
compare the rest of measures used for evaluation of the
treatment plans. The doses allowed to certain critical or-
gans can differ between treatment protocols implemented
in other centers. We have chosen the dose constraints used
in our Department which can be considered relatively con-
servative. A potential drawback of the study can also be
the assumption that all the lesions will be treated with
hypofractionated stereotactic radiotherapy. It is importantto note that we have selected only high-grade and critically
located AVMs for the purposes of this study. Some of them
were previously treated with embolization without success
and in any of them we would not propose a single fraction
treatment due to either large volume or critical location of
the lesion or both. Hypofractionated stereotactic radiother-
apy is a treatment modality used in our institution in such
cases [4]. Volume-staged radiosurgery would be extremely
difficult to implement in our study because between con-
secutive treatments some changes in the AVM shape and
volume could be expected which would make the compari-
sons irrelevant.
The most significant difference between the systems
was the number of monitor units required to deliver the
planned dose. This finding is in line with dosimetric
comparisons of robotic radiosurgery and linac-based sys-
tems in other locations [25,26]. Roughly tenfold higher
number of monitor units needed in the CK systems
leads to significant elongation of the treatment time. It
can be of importance in case of patients whose medical
condition does not allow for long irradiation. On the
other hand, AVMs are diagnosed mainly in young and
middle-aged patients which allows for less restricted
constraints concerning the treatment time than for ex-
ample in case of patients with disseminated neoplastic
disease irradiated for cerebral metastases.
Conclusions
Both systems allow for irradiation of complex-shaped
and large target volumes surrounded by critical struc-
tures with satisfactory coverage but neither is able to
generate satisfactory dose gradients outside such lesion.
Better conformity of the plans is an argument in favor of
choosing the CyberKnife system for irradiation of lesions
close to OARs. On the other hand, better homogeneity
of the plans made for linear accelerator with micro-
multileaf collimator along with significantly smaller
number of monitor units needed to complete the treat-
ment can favor this system in patients unable to main-
tain the treatment position for long time or in cases
where homogeneous dose distribution is preferred and
the occurrence of hotspots is of special concern.Competing interests
SB - Travel grant from TMS Sp. z o.o., AG - Employed as a translator of
CyberKnife manuals, travel grant, LM- Travel grant from Varian (Varian
Blamek et al. Radiation Oncology 2013, 8:205 Page 9 of 9
http://www.ro-journal.com/content/8/1/205Oncology Summit - 2011), consultancy, agreement with Varian concerning
educational activity.
Authors’ contributions
SB provided design of the study, analyzed the treatment plans, performed
the statistical analysis, revised the literature and prepared the manuscript,
AG prepared the treatment plans and helped in their analysis and
preparation of the manuscript, LM participated in coordination and helped
to draft the manuscript. All authors have read and approved the final
manuscript.
Author details
1Department of Radiotherapy, Maria Skłodowska-Curie Memorial Cancer
Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
2Department of Radiotherapy and Brachytherapy Planning, Maria
Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
Branch, ul. Wybrzeże AK 15, 44-100, Gliwice, Poland.
Received: 11 April 2013 Accepted: 20 August 2013
Published: 23 August 2013
References
1. Hernesniemi JA, Dashti R, Juvela S, Väärt K, Niemelä M, Laakso A: Natural
history of brain arteriovenous malformations: a long-term follow-up study
of risk of hemorrhage in 238 patients. Neurosurgery 2008, 63:823–829.
2. Laakso A, Dashti R, Seppänen J, Juvela S, Väärt K, Niemelä M, Sankila R,
Hernesniemi JA: Long-term excess mortality in 623 patients with brain
arteriovenous malformations. Neurosurgery 2008, 63:244–253.
3. Fogh S, Ma L, Gupta N, Sahgal A, Nakamura JL, Barani I, Sneed PK,
McDermott M, Larson DA: High-precision volume-staged Gamma Knife
surgery and equivalent hypofractionation dose schedules for treating
large arteriovenous malformations. J Neurosurg 2012, 117(Suppl):115–119.
4. Blamek S, Larysz D, Miszczyk L, Idasiak A, Rudnik A, Tarnawski R:
Hypofractionated stereotactic radiotherapy for large or involving
critical organs cerebral arteriovenous malformations. Radiol Oncol 2013,
47:50–56.
5. Steiner L, Leksell L, Greitz T, Forster DM, Backlund EO: Stereotaxic
radiosurgery for cerebral arteriovenous malformations. Report of a case.
Acta Chir Scand 1972, 138:459–464.
6. Kihlstrom L, Guo WY, Karlsson B, Lindquist C, Lindquist M: Magnetic
resonance imaging of obliterated arteriovenous malformations up to 23
years after radiosurgery. J Neurosurg 1997, 86:589–593.
7. Colombo F, Pozza F, Chierego G, Casentini L, De Luca G, Francescon P:
Linear accelerator radiosurgery of cerebral arteriovenous malformations:
an update. Neurosurgery 1994, 34:14–20.
8. Steinberg GK, Fabrikant JI, Marks MP, Levy RP, Frankel KA, Phillips MH, Shuer
LM, Silverberg GD: Stereotactic heavy-charged particle Bragg-peak
radiation for intracranial arteriovenous malformations. N Engl J Med 1990,
323:96–101.
9. Colombo F, Cavedon C, Casentini L, Francescon P, Causin F, Pinna V: Early
results of CyberKnife radiosurgery for arteriovenous malformations.
J Neurosurg 2009, 111:807–819.
10. Wowra B, Muacevic A, Tonn JC, Schoenberg SO, Reiser M, Herrmann KA:
Obliteration dynamics in cerebral arteriovenous malformations after
cyberknife radiosurgery: quantification with sequential nidus volumetry
and 3-tesla 3-dimensional time-of-flight magnetic resonance
angiography. Neurosurgery 2009, 64(Suppl 2):A102–A109.
11. Gevaert T, Levivier M, Lacornerie T, Verellen D, Engels B, Reynaert N, Tournel
K, Duchateau M, Reynders T, Depuydt T, Collen C, Lartigau E, De Ridder M:
Dosimetric comparison of different treatment modalities for stereotactic
radiosurgery of arteriovenous malformations and acoustic neuromas.
Radiother Oncol 2013, 106:192–197.
12. Pollock BE, Flickinger JC: Modification of the radiosurgery-based
arteriovenous malformation grading system. Neurosurgery 2008, 63:239–243.
13. IRIS™ variable aperture collimator for the Cyberknife® robotic radiosurgery
system: design, beam properties, and clinical benefits, Accuray Incorporated
2008. :7–9. http://www.cyberknife.com.tr/images/yayin/Iris_Whitepaper.pdf.
14. Wiggenraad RG, Petoukhova AL, Versluis L, van Santvoort JP: Stereotactic
radiotherapy of intracranial tumors: a comparison of intensity-
modulated radiotherapy and dynamic conformal arc. Int J Radiat Oncol
Biol Phys 2009, 74:1018–1026.15. Sharma SD, Jalali R, Phurailatpam RD, Gupta T: Does intensity-modulated
stereotactic radiotherapy achieve superior target conformity than
conventional stereotactic radiotherapy in different intracranial tumours?
Clin Oncol (R Coll Radiol) 2009, 21:408–416.
16. Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoli R, Martin L:
Radiation Therapy Oncology Group: Radiosurgery quality assurance
guidelines. Int J Radiat Oncol Biol Phys 1993, 27:1231–1239.
17. Lomax NJ, Scheib SG: Quantifying the degree of conformity in
radiosurgery treatment planning. Int J Radiat Oncol Biol Phys 2003,
55:1409–1419.
18. van't Riet A, Mak AC, Moerland MA, Elders LH, van der Zee W: A
conformation number to quantify the degree of conformality in
brachytherapy and external beam irradiation: application to the
prostate. Int J Radiat Oncol Biol Phys 1997, 37:731–736.
19. Wagner TH, Bova FJ, Friedman WA, Buatti JM, Bouchet LG, Meeks SL: A
simple and reliable index for scoring rival stereotactic radiosurgery
plans. Int J Radiat Oncol Biol Phys 2003, 57:1141–1149.
20. Ohtakara K, Hayashi S, Tanaka H, Hoshi H: Dosimetric comparison of 2.5
mm vs. 3.0 mm leaf width micro-multileaf collimator-based treatment
systems for intracranial stereotactic radiosurgery using dynamic
conformal arcs: implications for treatment planning. Jpn J Radiol 2011,
29:630–638.
21. Dutta D, Balaji Subramanian S, Murli V, Sudahar H, Gopalakrishna Kurup PG,
Potharaju M: Dosimetry comparison of Linac-based (BrainLAB) and
robotic radiosurgery (CyberKnife) stereotactic system plans for acoustic
schwannoma. J Neurooncol 2012, 106:637–642.
22. Yu C, Jozsef G, Apuzzo ML, Petrovich Z: Dosimetric comparison of
CyberKnife with other radiosurgical modalities for an ellipsoidal target.
Neurosurgery 2003, 53:1155–1162.
23. Blamek S, Boba M, Larysz D, Rudnik A, Ficek K, Eksner B, Miszczyk L,
Tarnawski R: The incidence of imaging abnormalities after stereotactic
radiosurgery for cerebral arteriovenous and cavernous malformations.
Acta Neurochir Suppl 2010, 106:187–190.
24. Flickinger JC, Kondziolka D, Lunsford LD, Kassam A, Phuong LK, Liscak R,
Pollock B: Development of a model to predict permanent symptomatic
postradiosurgery injury for arteriovenous malformation patients. Int J
Radiat Oncol Biol Phys 2000, 46:1143–1148.
25. Ding C, Chang CH, Haslam J, Timmerman R, Solberg T: A dosimetric
comparison of stereotactic body radiation therapy techniques for lung
cancer: robotic versus conventional linac-based systems. J Appl Clin Med
Phys 2010, 11:3223.
26. Atalar B, Aydin G, Gungor G, Caglar H, Yapici B, Ozyar E: Dosimetric
comparison of robotic and conventional linac-based stereotactic lung
irradiation in early-stage lung cancer. Technol Cancer Res Treat 2012,
11:249–255.
doi:10.1186/1748-717X-8-205
Cite this article as: Blamek et al.: Robotic radiosurgery versus micro-
multileaf collimator: a dosimetric comparison for large or critically
located arteriovenous malformations. Radiation Oncology 2013 8:205.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
